Immuno oncology is a type of cancer therapy designed to strengthen the body’s immune system to fight the cancer. These immunotherapies such as immune checkpoint inhibitor or cell transfer therapyimprove immune response of the patient against cancerous cells. Immunotherapies either act against immune checkpoint produced by cancer cells that reduces the intensity of immune responses towards them or stimulate the activities of specific components of the immune system. Immune checkpoint inhibitors is the most widely used therapy.
Increasing prevalence of cancer to fuel growth of immuno-oncology drugs market
According to World Health Organization (WHO), cancer is one of the major non-communicable diseases and the second-leading cause of death worldwide. According to International Agency for Research on Cancer (IARC) in 2012, there were around 14.1 million new cases, 8.8 million deaths, and 32.6 million people living with cancer worldwide. Immuno-oncology therapy is effective for treatment of cancers such as melanoma, bladder cancer, head and neck cancer, leukemia, lung, multiple myeloma, lymphoma, and renal cancer. Furthermore, immuno-oncology has less side effect than chemotherapy, radiation therapy, and surgery. There are many immuno-oncology drugs in the pipeline such as CAR-T cell therapy offered by Juno Therapeutics, Inc and Kite Pharma. Immuno-oncology drugs has proven clinical profile and increasing approvals to include more indicationfor existing drugs such as nivolumab is in turn expected to boost growth of the immuno-oncology drugs market.
However, high costs associated with therapy is restraining growth of the immuno-oncology drugs market. Immuno oncology drugs prescribed with chemotherapy increases the cancer treatment cost. According to Immuno-Oncology Summit Europe 2017, combination of immunotherapy with chemotherapy and targeted therapy improves survival rate of cancer patient. In 2017, Merck & Company received approval for immune checkpoint inhibitor brand Keytruda (pembrolizumab) for its use in combination with other anti-cancer drugs such as pemetrexed and carboplatin in non-squamous non-small cell lung cancer.
Immuno-oncology drugs market taxonomy:
On the basis of immunotherapy type:
On the basis of cancer type:
On the basis of distribution channel:
U.S. to dominate the immuno-oncology drugs market, owing to high prevalence of cancer
The U.S. has a robust healthcare infrastructure and is characterized by high availability of novel anti-cancer therapy options. According to a report published in American Cancer Society’s Cancer Journal for Clinicians, around 1,735,350 new cancer cases are estimated to be diagnosed in 2018 in U.S., including around 87,290 cases of melanoma, for which drugs such as ipilimumab (Brand-Yeroy) and pembrolimumab (Brand-Keytruda) have been approved. Furthermore, expansion of indications for already approved drug would open up new opportunities for immuno-oncology market. Currently, atezolizumab (Brand-Tecentriq) is indicated for type of cancers such as melanoma, bladder cancer, head and neck cancer FDA granted accelerated approval to Tecentriq for the treatment of people with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin chemotherapy
Key players operating in the immuno-oncology drugs market include Amgen Inc., AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Merck & Co, F. Hoffmann-La Roche AG, Johnson & Johnson,, Novartis International AG, Abbvie, Inc., Pfizer Inc., EMD Serono, Inc. and Gilead Lifescinces Inc.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.